Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14M Sell
514,660
-119,550
-19% -$2.64M ﹤0.01% 1357
2026
Q1
$9M Buy
634,210
+436,175
+220% +$6.4M ﹤0.01% 1395
2025
Q4
$2.5M Buy
198,035
+113,319
+134% +$1.67M ﹤0.01% 1993
2025
Q3
$1.27M Buy
84,716
+47,508
+128% +$766K ﹤0.01% 2286
2025
Q2
$585K Buy
37,208
+24,678
+197% +$374K ﹤0.01% 2529
2025
Q1
$234K Buy
12,530
+540
+5% +$11.8K ﹤0.01% 2808
2024
Q4
$286K Buy
11,990
+2,270
+23% +$63.4K ﹤0.01% 2509
2024
Q3
$272K Buy
9,720
+757
+8% +$21.4K ﹤0.01% 2437
2024
Q2
$226K Buy
+8,963
New +$186K ﹤0.01% 2379
2024
Q1
Sell
-62,841
Closed -$1.46M 2491
2023
Q4
$1.46M Sell
62,841
-794,650
-93% -$16M ﹤0.01% 1473
2023
Q3
$16.9M Sell
857,491
-283,183
-25% -$5.58M 0.03% 519
2023
Q2
$25.9M Buy
1,140,674
+194,175
+21% +$3.91M 0.06% 395
2023
Q1
$18.5M Buy
946,499
+401,468
+74% +$7.71M 0.04% 488
2022
Q4
$9.37M Buy
+545,031
New +$9.67M 0.02% 676

Other funds holding RXO

Cliff Asness's RXO Position: Q2 2026 in Review

Cliff Asness reduced its RXO (RXO) stake by 19% in Q2 2026, selling an estimated $2.64M and leaving 514,660 shares worth $14M. The position accounts for ﹤0.01% of the portfolio, ranked #1357.

Cliff Asness first reported a position in RXO in Q4 2022 and has held it in 14 quarters since. The position peaked at $25.9M in Q2 2023. 302 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Cliff Asness held 514,660 shares of RXO worth $14M as of Q2 2026.
  • Cliff Asness sold 119,550 RXO shares in Q2 2026, an estimated $2.64M.
  • RXO made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1357 holding.
  • Cliff Asness first reported a position in RXO in Q4 2022 and has held it in 14 quarters since.
  • Cliff Asness's RXO position peaked at $25.9M in Q2 2023.
  • 302 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.